Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
Dermatologicals is seeing solid current value growth in 2023, driven in part by higher retail prices. The category is benefiting from a return to normal daily lifestyles following the COVID-19 pandemic. Consumers’ skin is being more exposed to…
The incidence of head lice is rising back to normal levels in 2023 as children circulate freely in schools and at social gatherings, and kids play close together. With retail volume sales back to pre-pandemic levels in 2022, demand for…
Dermatologicals is seeing steady single-digit growth in current value terms in 2023. Two of the most important product areas, topical antifungals and vaginal antifungals, are both seeing moderate growth in 2023, although this is largely due to…
Dermatologicals has seen a return to growth in current value terms in 2023, which is mainly due to the waning impact of COVID-19 on consumer lifestyles and behaviours. Antipruritics is one of the largest categories within dermatologicals and has also…
Over 2023, dermatologicals is expected to see fast retail current value growth across categories, supported by rising prices amid a highly inflationary climate. In retail volume terms, growth is set to be positive, if more moderate than in current…
While overall consumer awareness of skin diseases and infections is increasing in Kenya, there remain areas where stigma persists, creating a reluctance among consumers to seek help. For instance, vaginal antifungals are linked to the stigma of…
Although dermatologicals continues to enjoy steady growth in 2023, current value sales have slowed down compared to the double-digit rates seen at the height of the COVID-19 pandemic. Whilst spending more time at home, Latvian consumers became…
The dermatologicals landscape is experiencing a downward momentum in some categories, which have found themselves losing share and importance following the outbreak of COVID-19. Topical Germicidals/Antiseptics is one of the categories which is set to…
Dermatologicals saw an overall increase in demand in 2023, although performance varied somewhat by subcategory Nappy (diaper) rash treatments, for example, benefited from the return of consumers to more active lifestyles outside the home, which meant…
While sales of dermatologicals continue to grow in 2023, reflecting a recovery from pandemic-related disruptions. demand is stabilising. Mexicans are no longer facing increased risks to their skin compared to the previous year, and some…